Cardiovascular Drugs
You are here:
RegeneRx is focused on the discovery and development of novel peptides to accelerate tissue and organ repair. ..
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, hea..
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled re..
Osiris Therapeutics, Inc. is a stem cell therapeutic company focused on developing products to treat medical conditions in the inflammatory, orthopedi..
PolyMedix, Inc. is an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascula..
Opexa Therapeutics is developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, cardiovascular disease,..
Molecular Insight Pharmaceuticals is a pioneer in the emerging field of molecular medicine...
Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease..
ImaRx Therapeutics is a development-stage biopharmaceutical company focused on the development of new treatments for vascular disorders...
Cardiovascular Systems Inc. (CSI) is comprised of a highly experienced, uniquely qualified team of experts experienced in the assessment, development ..
Bioheart is a biotechnology company focused on the treatment of chronic, acute heart damage, and peripheral vascular disease. ..
ARCA biopharma, Inc. (formerly Novelo) is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovasc..

